Lv4
720 积分 2023-09-15 加入
A multicentre randomized double-blind placebo-controlled phase III study of the efficacy and safety of xeligekimab (GR1501) in patients with moderate-to-severe plaque psoriasis
1天前
待确认
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
1个月前
已完结
Which medicines, taken by mouth or injected, work best to treat plaque psoriasis (a skin condition with raised patches)?
1个月前
已关闭
Safety of interleukin inhibitors in patients with plaque psoriasis and history of neoplasms: a multicenter retrospective study – IL PSO (Italian landscape psoriasis)
1个月前
已完结
[Translated article] BIOBADATOP Spanish Atopic Dermatitis Registry: Description and Early Findings
3个月前
已关闭
The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
3个月前
已完结
Secukinumab re‐initiation achieves regain of high response levels in patients who interrupt treatment for moderate to severe plaque psoriasis
4个月前
已完结
Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: A randomized, double-blind, placebo-controlled phase 3 trial
4个月前
已完结
Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: A randomized, double-blind, placebo-controlled phase 3 trial
5个月前
已完结
皖公网安备34019202002308
